ArticleDiabetology & metabolic syndrome2023

The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot study.

Mateus Paiva Marques Feitosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.